Real world evidence, patient centricity and new digital experiences are among the top 15 trends set to change clinical research and treatment commercialisation in 2020, according to Syneos
UK-based Masters Speciality Pharma focuses on supplying medicines to developing countries where access to treatments is limited – partnering with big pharma firms such as Novartis, Alex
Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe in the coming months in rheumatoid arthritis, after a p
The great and the good of pharma and biotech descended on London to give investors updates on how their businesses are progressing at this year’s Jefferies conference, and provided insights